|
BAZ1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.505970E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.641030E-03 |
| Normal-vs-Stage2 |
1.703850E-01 |
| Normal-vs-Stage3 |
5.806000E-01 |
| Normal-vs-Stage4 |
1.991180E-01 |
| Stage1-vs-Stage2 |
4.593400E-01 |
| Stage1-vs-Stage3 |
1.665920E-02 |
| Stage1-vs-Stage4 |
2.058400E-01 |
| Stage2-vs-Stage3 |
3.633000E-01 |
| Stage2-vs-Stage4 |
7.842200E-01 |
| Stage3-vs-Stage4 |
4.670000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.433700E-02 |
| Normal-vs-AfricanAmerican |
9.170600E-01 |
| Normal-vs-Asian |
8.360500E-02 |
| Caucasian-vs-AfricanAmerican |
1.046430E-01 |
| Caucasian-vs-Asian |
1.524590E-01 |
| AfricanAmerican-vs-Asian |
8.968000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.751900E-02 |
| Normal-vs-Female |
2.192500E-02 |
| Male-vs-Female |
7.751600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.693000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.501900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.574400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.227400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.361800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.010600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.004600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.584400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.227620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.559400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.833700E-02 |
| Normal-vs-Grade 2 |
2.902900E-03 |
| Normal-vs-Grade 3 |
2.147400E-01 |
| Normal-vs-Grade 4 |
2.595800E-01 |
| Grade 1-vs-Grade 2 |
2.203400E-01 |
| Grade 1-vs-Grade 3 |
4.643600E-02 |
| Grade 1-vs-Grade 4 |
1.774180E-01 |
| Grade 2-vs-Grade 3 |
3.776400E-02 |
| Grade 2-vs-Grade 4 |
3.535000E-01 |
| Grade 3-vs-Grade 4 |
7.450800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.024100E-04 |
| Normal-vs-ccB subtype |
1.053570E-01 |
| ccA subtype-vs-ccB subtype |
6.209800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.689700E-02 |
| Normal-vs-N1 |
1.928990E-01 |
| N0-vs-N1 |
3.873400E-01 |
|
|
